Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.24.2.u1
Stock-based Compensation (Tables)
6 Months Ended
Jun. 27, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The table below presents components of stock-based compensation expense within the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income:
Twenty-six Weeks Ended
in thousands June 27, 2024 June 29, 2023
General and administrative $ 13,458  $ 14,212 
Selling and store operating 2,129  835 
Total stock-based compensation expense $ 15,587  $ 15,047 
Stock Option Activity
The table below summarizes stock option activity for the twenty-six weeks ended June 27, 2024:
Options Weighted Average Exercise Price
Outstanding at December 29, 2023
1,607,341  $ 28.51 
Exercised (283,357) $ 19.21 
Forfeited or expired (2,041) $ 71.17 
Outstanding at June 27, 2024
1,321,943  $ 30.43 
Vested and exercisable at June 27, 2024
1,306,746  $ 29.68 
Restricted Stock Unit Activity
The following table summarizes restricted stock unit activity during the twenty-six weeks ended June 27, 2024:
Restricted Stock Units
Service-based Performance-based Total shareholder return Total Restricted Stock Units
Unvested at December 29, 2023 608,140  188,543  58,854  855,537 
Granted 240,892  50,855  —  291,747 
Vested (196,636) —  —  (196,636)
Forfeited (24,403) (13,001) (4,204) (41,608)
Unvested at June 27, 2024 627,993  226,397  54,650  909,040 
Restricted Stock Award Activity
The following table summarizes restricted stock award activity during the twenty-six weeks ended June 27, 2024:
Restricted Stock Awards
Service-based Performance-based (1) Total shareholder return (1) Total Restricted Stock Awards
Unvested at December 29, 2023 34,783  47,662  31,056  113,501 
Vested (30,680) (47,662) (31,056) (109,398)
Forfeited (395) —  —  (395)
Unvested at June 27, 2024 3,708  —  —  3,708 
(1) The performance-based and total shareholder return restricted stock awards that vested during the period were issued at 100% of target based on achievement of the predetermined performance and total shareholder return criteria as specified in the underlying grant agreements.